Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 75th Annual Meeting of the American College of Rheumatology
Rapid Treatment Response in Rheumatoid Arthritis: A Valuable Indicator of Reduced Risk of Joint Damage
Chicago, Illinois / November 5-9, 2011
Chicago - Previously, tight, early control of rheumatoid arthritis has been associated with less disease activity and fewer symptoms when measured over 1 year. New data with biologics associate early control with a reduction in structural...
ABSTRACTS in PERSPECTIVE - based on presentations from the 12th Annual European Congress of Rheumatology (EULAR)
Complete Remission as a Therapeutic Goal in Rheumatoid Arthritis: Accelerating Research with Biologics and Through New Inflammatory Pathways
London, UK / May 25-28, 2011
EDITORIAL OVERVIEW: Alfred A. Cividino, MD, FRCPC Clinical Professor of Medicine, Division of Rheumatology, McMaster University, Hamilton, Ontario A gents highly targeted at key molecular steps in the inflammatory process have...
MEDICAL FRONTIERS - 12th Annual European Congress of Rheumatology (EULAR)
Expanding Research in Intracellular Signalling: Promising Data in Rheumatoid Arthritis with Small-molecule Inhibitors
London, UK / May 25-28, 2011
Chief Medical Editor: Dr. Léna Coïc, Montréal, Québec The biologic agents first introduced for the treatment of rheumatoid arthritis (RA) more than a decade ago have provided unprecedented control in patients...
MEDICAL FRONTIERS - 12th Annual European Congress of Rheumatology (EULAR)
Preventing Rheumatoid Arthritis Progression: A Recent Demonstration of the Efficacy of Biologics
London, UK / May 25-28, 2011
London - Relative to disease-modifying antirheumatic drugs (DMARDs), the targeted biologic agents have demonstrated remarkable efficacy, often achieving full restoration of function in patients with refractory and disabling symptoms. It has...
PRIORITY PRESS - 12th Annual European Congress of Rheumatology (EULAR)
Success of Biologics in Rheumatoid Arthritis: From Efficacy of IL-6 Inhibition to Validation of Targeting New Inflammatory Pathways
London, UK / May 25-28, 2011
London - Current biologics, which include tumour necrosis factor (TNF) and interleukin-6 (IL-6) receptor inhibitors, act by exerting control over key molecular steps in the inflammatory process of rheumatoid arthritis (RA). Their ability to...
PRIORITY PRESS - 12th Annual European Congress of Rheumatology (EULAR)
New Treatment Option for Gout-related Hyperuricemia
London, UK / May 25-28, 2011
Until recently, treatment of gout involved either enhancement of renal uric acid excretion with a uricosuric, such as probenecid, or inhibition of urate production with the purine-based analogue allopurinol, a xanthine oxidase inhibitor....
PRIORITY PRESS - 12th Annual European Congress of Rheumatology (EULAR)
Insights Into Tight Rheumatoid Arthritis Control and Treating-to-Target Approaches
London, UK / May 25-28, 2011
London - Experts at this year’s EULAR agreed that rapid control of inflammation is essential in rheumatoid arthritis (RA). In 2010, the EULAR guidelines were revised to define the treatment goal as an absence of signs and symptoms as well...
JOURNAL CLUB - Rheumatology
Tight Disease Control and Treating to Target in Rheumatoid Arthritis: An International Task Force Perspective
December 2010
Based on Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69(4):631-7 and Presentations from the 2010 Annual European Congress of Rheumatology (EULAR) Rome, Italy / June 16-19,...
MEDICAL FRONTIERS - 61st Annual Refresher Course for Family Physicians
Disease Prevention in Primary Care
McGill University, Montreal, Quebec / November 28-December 1, 2010
Which Lifestyle Changes Are Effective? Lifestyle measures can promote overall health, prevent disease and extend life. In patients already taking antihypertensive or lipid-lowering therapy, lifestyle modification may be more effective than...